The role of glial cells in mental illness: a systematic review on astroglia and microglia as potential players in schizophrenia and its cognitive and emotional aspects
- PMID: 38419655
- PMCID: PMC10899480
- DOI: 10.3389/fncel.2024.1358450
The role of glial cells in mental illness: a systematic review on astroglia and microglia as potential players in schizophrenia and its cognitive and emotional aspects
Abstract
Schizophrenia is a complex and severe mental disorder that affects approximately 1% of the global population. It is characterized by a wide range of symptoms, including delusions, hallucinations, disorganized speech and behavior, and cognitive impairment. Recent research has suggested that the immune system dysregulation may play a significant role in the pathogenesis of schizophrenia, and glial cells, such as astroglia and microglia known to be involved in neuroinflammation and immune regulation, have emerged as potential players in this process. The aim of this systematic review is to summarize the glial hallmarks of schizophrenia, choosing as cellular candidate the astroglia and microglia, and focusing also on disease-associated psychological (cognitive and emotional) changes. We conducted a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched PubMed, Scopus, and Web of Science for articles that investigated the differences in astroglia and microglia in patients with schizophrenia, published in the last 5 years. The present systematic review indicates that changes in the density, morphology, and functioning of astroglia and microglia may be involved in the development of schizophrenia. The glial alterations may contribute to the pathogenesis of schizophrenia by dysregulating neurotransmission and immune responses, worsening cognitive capabilities. The complex interplay of astroglial and microglial activation, genetic/epigenetic variations, and cognitive assessments underscores the intricate relationship between biological mechanisms, symptomatology, and cognitive functioning in schizophrenia.
Keywords: GFAP; Iba1; cognitive symptoms; immune system; inflammatory pathways.
Copyright © 2024 Laricchiuta, Papi, Decandia, Panuccio, Cutuli, Peciccia, Mazzeschi and Petrosini.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
Similar articles
-
Anti-Inflammatory Diets and Schizophrenia.Clin Nutr Res. 2020 Oct 28;9(4):241-257. doi: 10.7762/cnr.2020.9.4.241. eCollection 2020 Oct. Clin Nutr Res. 2020. PMID: 33204665 Free PMC article. Review.
-
[A rare and not very studied disorder: childhood-onset schizophrenia. A case report].Encephale. 2004 Nov-Dec;30(6):540-7. doi: 10.1016/s0013-7006(04)95468-1. Encephale. 2004. PMID: 15738856 French.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
-
Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation.Epilepsia. 2014 Jan;55(1):184-92. doi: 10.1111/epi.12473. Epub 2013 Dec 2. Epilepsia. 2014. PMID: 24299259
-
Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics.J Neuropathol Exp Neurol. 2000 Feb;59(2):137-50. doi: 10.1093/jnen/59.2.137. J Neuropathol Exp Neurol. 2000. PMID: 10749103
Cited by
-
Urolithin A alleviates schizophrenic-like behaviors and cognitive impairment in rats through modulation of neuroinflammation, neurogenesis, and synaptic plasticity.Sci Rep. 2025 Mar 26;15(1):10477. doi: 10.1038/s41598-025-93554-9. Sci Rep. 2025. PMID: 40140679 Free PMC article.
-
The Role of Neuroglia in the Development and Progression of Schizophrenia.Biomolecules. 2024 Dec 25;15(1):10. doi: 10.3390/biom15010010. Biomolecules. 2024. PMID: 39858403 Free PMC article. Review.
-
Role of Glial Trace Amine Associated Receptor 1 (TAAR1) and Microbiota in Schizophrenia.Neurochem Res. 2025 Aug 21;50(5):273. doi: 10.1007/s11064-025-04525-5. Neurochem Res. 2025. PMID: 40839091 Review.
-
The Underlying Neurobiological Mechanisms of Psychosis: Focus on Neurotransmission Dysregulation, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction.Antioxidants (Basel). 2024 Jun 12;13(6):709. doi: 10.3390/antiox13060709. Antioxidants (Basel). 2024. PMID: 38929148 Free PMC article. Review.
-
Glial cell deficits are a key feature of schizophrenia: implications for neuronal circuit maintenance and histological differentiation from classical neurodegeneration.Mol Psychiatry. 2025 Mar;30(3):1102-1116. doi: 10.1038/s41380-024-02861-6. Epub 2024 Dec 5. Mol Psychiatry. 2025. PMID: 39639174 Free PMC article. Review.
References
-
- Amoah S. K., Rodriguez B. A., Logothetis C. N., Chander P., Sellgren C. M., Weick J. P., et al. (2020). Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychotics. Neuropsychopharmacology 45 656–665. 10.1038/s41386-019-0579-1 - DOI - PMC - PubMed
-
- Barker A. J., Ullian E. M. (2010). Astrocytes and synaptic plasticity. Neuroscientist 16 40–50. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous